Specific Lipid and Metabolic Profiles of R-CHOP-Resistant Diffuse Large B-Cell Lymphoma Elucidated by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging and in Vivo Imaging

[Image: see text] Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell non-Hodgkin lymphoma. To treat this aggressive disease, R-CHOP, a combination of immunotherapy (R; rituximab) and chemotherapy (CHOP; cyclophosphamide, doxorubicin, vincristine, and prednisone), remains the most common...

Descripción completa

Detalles Bibliográficos
Autores principales: Barré, Florian P.Y., Claes, Britt S.R., Dewez, Frédéric, Peutz-Kootstra, Carine, Munch-Petersen, Helga F., Grønbæk, Kirsten, Lund, Anders H., Heeren, Ron M.A., Côme, Christophe, Cillero-Pastor, Berta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328237/
https://www.ncbi.nlm.nih.gov/pubmed/30422637
http://dx.doi.org/10.1021/acs.analchem.8b02910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328237/
https://www.ncbi.nlm.nih.gov/pubmed/30422637
http://dx.doi.org/10.1021/acs.analchem.8b02910

Ejemplares similares